Cancer and Radiosensitivity Syndromes: Is Impaired Nuclear ATM Kinase Activity the Primum Movens?

Laura El Nachef1, Elise Berthel1, Mélanie L Ferlazzo1

  • 1Inserm, U1296 Unit, Radiation: Defense, Health and Environment, Centre Léon-Bérard, 69008 Lyon, France.

Cancers
|December 23, 2022
PubMed

Insights

Genetic syndromes link high cancer risk and radiosensitivity through ATM kinase. Mutations in ATM phosphorylation substrates, often cytoplasmic, explain this connection, unifying cancer proneness and radiation sensitivity.

Area of Science:

  • Genetics
  • Molecular Biology
  • Radiation Oncology

Background:

  • Genetic syndromes often present with both increased cancer risk and clinical radiosensitivity.
  • The underlying molecular mechanisms connecting these two phenomena remain largely unknown.
  • Mutations in DNA repair, signaling, or cell cycle control genes are implicated in various cancer syndromes.

Purpose of the Study:

  • To explore a unified mechanistic model explaining the link between cancer proneness and radiosensitivity.
  • To investigate the role of ATM kinase and its phosphorylation substrates in this context.
  • To analyze how mutations affecting ATM substrates contribute to cancer and radiation sensitivity.

Main Methods:

  • Review and discussion of the radiation-induced nucleoshuttling of ATM kinase (RIANS) model.
  • Analysis of known cancer and radiosensitivity syndromes within the framework of the RIANS model.
  • Examination of the subcellular localization and phosphorylation status of mutated proteins.

Main Results:

  • The RIANS model provides a potential unified explanation for the co-occurrence of cancer proneness and radiosensitivity.
  • Mutated proteins responsible for major cancer and radiosensitivity syndromes are identified as ATM phosphorylation substrates.
  • These mutated proteins frequently exhibit cytoplasmic localization.

Conclusions:

  • The RIANS model offers a framework to understand how mutations in ATM substrates contribute to both cancer development and cellular radiosensitivity.
  • Cytoplasmic localization of mutated ATM substrates may be a key factor in these syndromes.
  • Further investigation into the RIANS model could elucidate the interplay between DNA damage response and cancer predisposition.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K